DKP
TVGNW icon

Davidson Kempner Partners’s Tevogen Bio Warrant TVGNW Stock Holding History

Davidson Kempner Partners’s Portfolio TVGNW Stock Details TVGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$20K Buy
+250,000
New +$13.8K ﹤0.01% 281

Other funds holding TVGNW

LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
FCM
FourWorld Capital Management New York $196M AUM 42.39% 1-Year Est. Return
CCP
Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

Davidson Kempner Partners's TVGNW Position: Q1 2023 in Review

Davidson Kempner Partners opened a new position in Tevogen Bio Warrant (TVGNW) in Q1 2023: 250,000 shares worth $20K. The stake represents ﹤0.01% of the portfolio and ranks #281 among its holdings.

55 funds tracked by Wall St. Rank hold TVGNW as of Q1 2023.

  • Davidson Kempner Partners held 250,000 shares of Tevogen Bio Warrant worth $20K as of Q1 2023.
  • Tevogen Bio Warrant was a new Davidson Kempner Partners position in Q1 2023.
  • Tevogen Bio Warrant made up ﹤0.01% of Davidson Kempner Partners's portfolio in Q1 2023, its #281 holding.
  • 55 funds tracked by Wall St. Rank held Tevogen Bio Warrant as of Q1 2023.

Based on Davidson Kempner Partners's 13F filing for Q1 2023, filed 15 May 2023.